Publications

Sodiomon B Sirima, Laura Richert, Arnaud Chêne, Amadou T Konate, Cécilia Campion, Sébastien Dechavanne, Jean-Philippe Semblat, Nadine Benhamouda, Mathilde Bahuaud, Pierre Loulergue, Alphonse Ouédraogo, Issa Nébié, Moïse Kabore, Désiré Kargougou, Aïssata Barry, San Maurice Ouattara, Valérie Boilet, Florence Allais, Gwenaelle Roguet, Nicolas Havelange, Elvira Lopez-Perez, Alexis Kuppers, Eleine Konaté, Caroline Roussillon , Myriam Kanté, Linda Belarbi, Amidou Diarra, Noelie Henry, Issiaka Soulama, Amidou Ouédraogo, Helene Esperou, Odile Leroy, Frederic Batteux, Eric Tartour, Nicola K Viebig, Rodolphe Thiebaut, Odile Launay, Benoît Gamain. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. 2020. The Lancet Infectious Diseases. 20. 585-597.

Leroi I, Armitage CJ, Collin F, Frison E, Hann M, Hooper E, Reeves D, Simkin Z, Wolski L and the SENSE-Cog Work Package 3 investigators. A randomised controlled trial of hearing and vision support in dementia: Protocol for a process evaluation in the SENSE-Cog trial. 2020. Trials. 21. 223.

Lhomme E, Hejblum BP, Lacabaratz C, Wiedemann A, Lelièvre JD, Levy Y, Thiébaut R, Richert L.. Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect. 2020. Journal of Immunological Methods. 477. 112711.

Andrew J Pollard, Odile Launay, Jean-Daniel Lelievre, Christine Lacabaratz, Sophie Grande, Neil Goldstein, Cynthia Robinson, Auguste Gaddah,Viki Bockstal, Aurelie Wiedemann, Maarten Leyssen, Kerstin Luhn, Laura Richert, Christine Bétard, Malick M Gibani, Elizabeth A Clutterbuck, Matthew D Snape, Yves Levy, Macaya Douoguih, Rodolphe Thiebaut ; EBOVAC2 EBL2001 study group. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN®-Filo Ebola vaccine regimen: a phase 2 randomised clinical study in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. 2020. Lancet Infectious Diseases. 21. 493-506.

Edouard Lhomme, Camara Modet, Augustin Augier, Sylvain Faye, Tienhan Sandrine Dabakuyo-Yonli, Claire Levy-Marchal, Eric D’Ortenzio, Yazdan Yazdanpanah, Geneviève Chêne, Abdoul Habib Beavogui, Laura Richert & the PREVAC study team. Enrolling study personnel in Ebola Vaccine trials: From Guidelines to practice in a non-epidemic context. 2019. Trials. 20. 422.

Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I and for the SENSE-Cog Trial Development Team. Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial. 2019. Trials. 20. 80.

Moore C, Stöhr W, Crook A, Richert L, Leliévre JD, Pantaleo G, García F, Vella S, Lévy Y, Thiébaut R, McCormack S. Multi-arm multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. 2019. Lancet HIV. 6. e334-e340.

Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous A, Collin F, Constantinidou F, Dawes P, Elliott R, Falkingham S, Frison E, Hann M, Helmer C, Himmelsbach I, Hussain H, Marié S, Montecelo S, Reeves D, Regan J, Thodi C, Wolski L, and Leroi I. Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial. 2019. Journal of the American Geriatrics Society. 67. 1472-1477.

Iracema Leroi, Zoe Simkin, Emma Hooper, Lucas Wolski, Harvey Abrams, Christopher J Armitage, Elizabeth Camacho, Anna Pavlina Charalambous, Fideline Collin, Fofi Constantinidou, Piers Dawes, Rachel Elliott, Sue Falkingham, Eric Frison, Mark Hann, Catherine Helmer, Ines Himmelsbach, Hannah Hussain, Sarah Marié, Susana Montecelo, Chryssoula Thodi, Wai Kent Yeung. Impact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field Trial. 2019. International Journal of Geriatric Psychiatry. 35. 348-357.